Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America

Leonard A. Mermel, Michael Allon, Emilio Bouza et al. · Clinical Infectious Diseases · 2009 · 3.6K citations · Full text

Medicine, Infectious Diseases, Infection Prevention +12

Multiplex PCR for detection of acquired carbapenemase genes

Laurent Poirel, Timothy R. Walsh, Vincent Cuvillier et al. · Diagnostic Microbiology and Infectious Disease · 2011 · 2K citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

Hajo Grundmann, Corinna Glasner, Barbara Albiger et al. · The Lancet Infectious Diseases · 2016 · 677 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Ceftazidime-Avibactam Is Superior to Other Treatment Regimens against Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

Ryan K. Shields, M. Hong Nguyen, Liang Chen et al. · Antimicrobial Agents and Chemotherapy · 2017 · 487 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and <i>Pseudomonas aeruginosa</i> with Difficult-to-Treat Resistance (DTR-<i>P. aeruginosa</i>)

Pranita D. Tamma, Samuel L Aitken, Robert A. Bonomo et al. · Clinical Infectious Diseases · 2020 · 427 citations

Life Sciences, Infectious Diseases, Microbiology +17